David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 109,312 shares at $25.65 ($2.8M) on 2011-05-31, disclosed to the SEC on 2011-06-01.
Scheduled sale ($2.8M) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.31 | 57,812 | $1.5M | 52.6% |
| 2 | $25.65 | 51,500 | $1.3M | 47.4% |
| Total | $25.47 avg | 109,312 | $2.8M | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |